For women considering black cohosh to support their well-being during midlife and menopause, understanding how the body processes it can be helpful. This involves looking at its pharmacokinetics: how it’s absorbed, metabolized, and eventually eliminated from the system.
While research into black cohosh pharmacokinetics is still developing, some insights are emerging. This article will explore what is currently understood about these processes, acknowledging the limited nature of the available evidence.
What are Pharmacokinetics?
Pharmacokinetics describe the journey of a substance within the body, often summarized by the acronym ADME: Absorption, Distribution, Metabolism, and Excretion. Absorption refers to how a substance enters the bloodstream; distribution describes where it travels in the body; metabolism is how the body chemically alters it; and excretion is how it leaves the body.
For black cohosh, understanding these processes is complex because it is a botanical extract containing numerous compounds, rather than a single chemical entity. The specific compounds responsible for its potential effects are still being investigated, which makes tracking its ADME challenging.
Absorption of Black Cohosh Compounds
Absorption is the first step in a substance entering the body’s circulation. For orally administered black cohosh, this means compounds must pass from the digestive tract into the bloodstream. The triterpene glycosides are often considered key components of black cohosh, and their absorption has been a focus of some research. However, the exact mechanisms and extent of their absorption are not fully clear [1].
One specific triterpene glycoside, 23-epi-26-deoxyactein, has been studied regarding its pharmacokinetics after oral administration of a standardized black cohosh extract in women. Research has shown that this compound can be detected in the bloodstream after ingestion, indicating some level of absorption [2]. However, the bioavailability, or the proportion of the absorbed dose that reaches systemic circulation, is still an area requiring more investigation for black cohosh’s diverse compounds [1].
Metabolism of Black Cohosh
Once absorbed, compounds from black cohosh undergo metabolism, primarily in the liver. Metabolism involves chemical transformations that can make compounds easier to excrete or, in some cases, activate them into more potent forms. The liver’s cytochrome P450 (CYP) enzyme system is a major player in drug metabolism, and interactions with this system are often a concern with herbal supplements [3].
Studies have explored whether black cohosh influences CYP enzymes. Some research suggests that black cohosh may have a limited effect on CYP3A activity, a major enzyme involved in metabolizing many medications [4]. However, other in vitro studies indicate that black cohosh may induce Cyp3a through pregnane X receptor-mediated pathways [5]. The clinical significance of these findings, particularly in humans, is still being evaluated and may depend on the specific extract and dosage. Generally, the metabolic pathways for many compounds found in the Ranunculaceae family, which includes black cohosh, are diverse and not fully elucidated [6].
It’s important to note that if a botanical significantly alters CYP enzyme activity, it could potentially affect the metabolism of other medications taken concurrently, either increasing or decreasing their levels in the body [3]. For instance, a study specifically looking at the effect of black cohosh supplementation on digoxin pharmacokinetics in humans found no significant impact [7]. This suggests that interactions may not occur with all medications, but caution is still warranted.
Excretion of Black Cohosh Compounds
Excretion is the process by which the body eliminates waste products and metabolized compounds. The kidneys are the primary organs of excretion, removing substances through urine, while the liver can excrete some compounds into bile, which is then eliminated in feces. For black cohosh, information on the specific excretion pathways and rates for its various components is limited.
While 23-epi-26-deoxyactein has been shown to be absorbed and detected in the body, its exact excretion profile, including half-life (the time it takes for half of the substance to be eliminated), is not extensively detailed in human studies [2]. Further research is needed to fully characterize how black cohosh compounds and their metabolites are cleared from the body.
Factors Influencing Pharmacokinetics
Several factors can influence the pharmacokinetics of black cohosh, including individual differences in metabolism, genetics, age, and the specific formulation or extract used. The chemical composition of black cohosh extracts can vary significantly depending on the plant source, processing methods, and standardization, which can impact how the body processes it [1].
Because black cohosh is a complex botanical, its pharmacokinetic profile is likely influenced by the interplay of multiple compounds rather than just one. This complexity makes comprehensive pharmacokinetic studies challenging but essential for a thorough understanding of its safety and potential effects.
References
- In Vitro and In Situ Characterization of Triterpene Glycosides From Cimicifuga racemosa Extract. Journal of pharmaceutical sciences, 2017
- Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh. Clinical pharmacology and therapeutics, 2010
- Drug interactions with herbal medicines. Clinical pharmacokinetics, 2012
- Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. Journal of clinical pharmacology, 2006
- Pregnane X receptor-mediated induction of Cyp3a by black cohosh. Xenobiotica; the fate of foreign compounds in biological systems, 2011
- Drug metabolism and pharmacokinetic diversity of ranunculaceae medicinal compounds. Current drug metabolism, 2015
- Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug metabolism and disposition: the biological fate of chemicals, 2006
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
